Longtek Biotechnology

Longtek Biotechnology is a specialized life sciences company focused on providing advanced bioprocessing solutions and high-purity fluid management for the biopharmaceutical industry. Headquartered in Suzhou, China, the company develops and manufactures a comprehensive portfolio of single-use technologies, including bioreactors, storage bags, and fluid transport systems. Their products are specifically designed to support the manufacturing of complex biologics such as monoclonal antibodies, vaccines, and advanced cell and gene therapies. As a key supplier and CDMO partner, Longtek provides high-quality alternatives for critical bioprocessing consumables, addressing the industry's need for flexibility and sterility. The company has secured significant backing from major healthcare investors like Hillhouse Capital and IDG Capital to expand its R&D and manufacturing capacity. Their focus on single-use systems helps biopharma companies reduce cross-contamination risks and speed up clinical-to-commercial timelines.